Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Vermeulen, Jeroen F ^a   van de Ven, Robert A H ^a   Ercan, Cigdem ^a   van der Groep, Petra ^a   van der Wall, Elsken ^a   Bult, Peter ^b   Christgen, Matthias ^c   Lehmann, Ulrich ^c   Daniel, Juliet ^d   van Diest, Paul J ^a   Derksen, Patrick W B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CATENIN; PROTEIN P120; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KAISO; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; INVASIVE LUNG CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME;

ADHERENS JUNCTIONS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; CELL LINE; CELL NUCLEUS; FEMALE; GENE EXPRESSION; HUMANS; MICE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; P120 GTPASE ACTIVATING PROTEIN; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSCRIPTION FACTORS;

EID: 84861463110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037864     Document Type: Article

References (61)

1. Daniel JM, Reynolds AB, (1999) The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19: 3614-3623.
2. Daniel JM, (2007) Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso. Biochim Biophys Acta 1773: 59-68.
3. van Roy FM, McCrea PD, (2005) A role for Kaiso-p120ctn complexes in cancer? Nat Rev Cancer 5: 956-964.
4. Daniel JM, Spring CM, Crawford HC, Reynolds AB, Baig A, (2002) The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res 30: 2911-2919.
5. Prokhortchouk A, Hendrich B, Jorgensen H, Ruzov A, Wilm M, et al. (2001) The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev 15: 1613-1618.
6. Ruzov A, Hackett JA, Prokhortchouk A, Reddington JP, Madej MJ, et al. (2009) The interaction of xKaiso with xTcf3: a revised model for integration of epigenetic and Wnt signalling pathways. Development 136: 723-727.
7. Ruzov A, Savitskaya E, Hackett JA, Reddington JP, Prokhortchouk A, et al. (2009) The non-methylated DNA-binding function of Kaiso is not required in early Xenopus laevis development. Development 136: 729-738.
8. Rodova M, Kelly KF, VanSaun M, Daniel JM, Werle MJ, (2004) Regulation of the rapsyn promoter by kaiso and delta-catenin. Mol Cell Biol 24: 7188-7196.
9. Kelly KF, Spring CM, Otchere AA, Daniel JM, (2004) NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J Cell Sci 117: 2675-2686.
10. Kim SW, Park JI, Spring CM, Sater AK, Ji H, et al. (2004) Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin. Nat Cell Biol 6: 1212-1220.
11. Del Valle-Perez B, Casagolda D, Lugilde E, Valls G, Codina M, et al. (2011) Wnt controls the transcriptional activity of Kaiso through CK1epsilon-dependent phosphorylation of p120-catenin. J Cell Sci 124: 2298-2309.
12. Park JI, Kim SW, Lyons JP, Ji H, Nguyen TT, et al. (2005) Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev Cell 8: 843-854.
13. Ruzov A, Dunican DS, Prokhortchouk A, Pennings S, Stancheva I, et al. (2004) Kaiso is a genome-wide repressor of transcription that is essential for amphibian development. Development 131: 6185-6194.
14. Soubry A, van Hengel J, Parthoens E, Colpaert C, Van Marck E, et al. (2005) Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment. Cancer Res 65: 2224-2233.
15. Donaldson NS, Nordgaard CL, Pierre CC, Kelly KF, Robinson SC, et al. (2010) Kaiso regulates Znf131-mediated transcriptional activation. Exp Cell Res 316: 1692-1705.
16. Prokhortchouk A, Sansom O, Selfridge J, Caballero IM, Salozhin S, et al. (2006) Kaiso-deficient mice show resistance to intestinal cancer. Mol Cell Biol 26: 199-208.
17. Berx G, van Roy F, (2009) Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1: a003129.
18. Derksen PW, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, et al. (2011) Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Model Mech 4: 347-358.
19. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, et al. (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10: 437-449.
20. Schackmann RC, van Amersfoort M, Haarhuis JH, Vlug EJ, Halim VA, et al. (2011) Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. J Clin Invest 121: 3176-3188.
21. van de Wetering M, Barker N, Harkes IC, van der Heyden M, Dijk NJ, et al. (2001) Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res 61: 278-284.
22. Dabbs DJ, Bhargava R, Chivukula M, (2007) Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 31: 427-437.
23. Sarrio D, Perez-Mies B, Hardisson D, Moreno-Bueno G, Suarez A, et al. (2004) Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene 23: 3272-3283.
24. Shibata T, Kokubu A, Sekine S, Kanai Y, Hirohashi S, (2004) Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer. Am J Pathol 164: 2269-2278.
25. van der Groep P, Bouter A, van der Zanden R, Menko FH, Buerger H, et al. (2004) Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 96: 712-713; author reply 714.
26. van der Groep P, Bouter A, van der Zanden R, Siccama I, Menko FH, et al. (2006) Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 59: 611-617.
27. Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H, (2003) Demystified tissue microarray technology. Mol Pathol 56: 198-204.
28. van Diest PJ, (2002) No consent should be needed for using leftover body material for scientific purposes. For. BMJ 325: 648-651.
29. Daniel JM, Ireton RC, Reynolds AB, (2001) Monoclonal antibodies to Kaiso: a novel transcription factor and p120ctn-binding protein. Hybridoma 20: 159-166.
30. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, et al. (2012) Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol 25: 398-404.
31. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
32. Christgen M, Bruchhardt H, Hadamitzky C, Rudolph C, Steinemann D, et al. (2009) Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer. J Pathol 217: 620-632.
33. Dai SD, Wang Y, Miao Y, Zhao Y, Zhang Y, et al. (2009) Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer. BMC Cancer 9: 178.
34. Siziopikou KP, Cobleigh M, (2007) The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. Breast 16: 104-107.
35. Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, et al. (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19: 264-271.
36. Takahashi K, Suzuki K, Tsukatani Y, (1997) Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence. Oncogene 15: 71-78.
37. Mariner DJ, Davis MA, Reynolds AB, (2004) EGFR signaling to p120-catenin through phosphorylation at Y228. J Cell Sci 117: 1339-1350.
38. Singh R, Lei P, Andreadis ST, (2009) PKC-delta binds to E-cadherin and mediates EGF-induced cell scattering. Exp Cell Res 315: 2899-2913.
39. van Hengel J, Vanhoenacker P, Staes K, van Roy F, (1999) Nuclear localization of the p120(ctn) Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression. Proc Natl Acad Sci U S A 96: 7980-7985.
40. Schonborn I, Zschiesche W, Behrens J, Herrenknecht K, Birchmeier W, (1997) Expression of E-cadherin/catenin complexes in breast cancer. Int J Oncol 11: 1327-1334.
41. Qureshi HS, Linden MD, Divine G, Raju UB, (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125: 377-385.
42. Gonzalez-Angulo AM, Sahin A, Krishnamurthy S, Yang Y, Kau SW, et al. (2006) Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin Breast Cancer 7: 396-400.
43. Kelly KF, Daniel JM, (2006) POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol 16: 578-587.
44. Costoya JA, Pandolfi PP, (2001) The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development. Curr Opin Hematol 8: 212-217.
45. Reljic R, Wagner SD, Peakman LJ, Fearon DT, (2000) Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med 192: 1841-1848.
46. Wagner SD, Ahearne M, Ferrigno PK, (2011) The role of BCL6 in lymphomas and routes to therapy. Br J Haematol 152: 3-12.
47. Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, et al. (2003) Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33: 197-202.
48. Lopes EC, Valls E, Figueroa ME, Mazur A, Meng FG, et al. (2008) Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines. Cancer Res 68: 7258-7263.
49. Park JI, Ji H, Jun S, Gu D, Hikasa H, et al. (2006) Frodo links Dishevelled to the p120-catenin/Kaiso pathway: distinct catenin subfamilies promote Wnt signals. Dev Cell 11: 683-695.
50. Peek RM, Ogden SR, Wroblewski LE, Weydig C, Romero-Gallo J, et al. (2008) p120 and Kaiso Regulate Helicobacter pylori-induced Expression of Matrix Metalloproteinase-7. Molecular Biology of the Cell 19: 4110-4121.
51. Iioka H, Doerner SK, Tamai K, (2009) Kaiso is a bimodal modulator for Wnt/beta-catenin signaling. FEBS Lett 583: 627-632.
52. Zhang PX, Wang Y, Liu Y, Jiang GY, Li QC, et al. (2011) p120-catenin isoform 3 regulates subcellular localization of Kaiso and promotes invasion in lung cancer cells via a phosphorylation-dependent mechanism. Int J Oncol 38: 1625-1635.
53. Perez-Moreno M, Davis MA, Wong E, Pasolli HA, Reynolds AB, et al. (2006) p120-catenin mediates inflammatory responses in the skin. Cell 124: 631-644.
54. Stairs DB, Bayne LJ, Rhoades B, Vega ME, Waldron TJ, et al. (2011) Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell 19: 470-483.
55. Smalley-Freed WG, Efimov A, Short SP, Jia P, Zhao Z, et al. (2011) Adenoma formation following limited ablation of p120-catenin in the mouse intestine. PLoS One 6: e19880.
56. Davis MA, Reynolds AB, (2006) Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev Cell 10: 21-31.
57. Dai SD, Wang Y, Zhang JY, Zhang D, Zhang PX, et al. (2011) Upregulation of delta-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer. Cancer Sci 102: 95-103.
58. Kelly KF, Otchere AA, Graham M, Daniel JM, (2004) Nuclear import of the BTB/POZ transcriptional regulator Kaiso. J Cell Sci 117: 6143-6152.
59. Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, et al. (2003) Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res 63: 7167-7175.
60. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, et al. (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15: 2523-2536.
61. de Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, et al. (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183: 404-411.